Broadstreet will be featuring seven of our research projects at ISPOR Europe 2025. Subjects range from health-related quality-of-life in hypophosphatasia to physician perspectives on unmet need and treatment options in relapsed advanced non-squamous non-small cell lung cancer.

We invite you to check out all our posters:

Physician Perspectives on Unmet Need and Treatment Options Among Patients with Relapsed Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings from Qualitative Interviews

Katherine Osenenko,¹ Cassandra Debard,¹ Rana Qadeer,² Martin Rupp,² Suzanne McMullen,¹ Tracey D’Cunha,³ Dr. Geoffrey Liu^4
1Broadstreet HEOR, Vancouver, BC, Canada; ²AstraZeneca Canada, Mississauga, ON, Canada; ³Daiichi Sankyo Pharma Canada, Toronto, ON, Canada; ⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Evaluating Patient Preferences for Clinical Trial Endpoints in Early-Stage Cancer: A Discrete Choice Experiment in Canada

Alexis T Mickle,¹ Frances Simbulan,² Bianca Li,² Kristoph Klein-Panneton,² Stephanie Snow,³ Conor L Morrison,¹ Karissa Johnston¹
¹Broadstreet HEOR, Vancouver, BC, Canada; ²AstraZeneca Canada, Mississauga, ON, Canada, ³QEII Health Sciences Centre, Dalhousie University, Halifax, NS, Canada

The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review

Antoinette Cheung,¹ Megan Manuel,¹ Stephen Mac, ² Romina Fakhraei,¹ Aidan Giangregorio,² Stephen D. Betschel^3
1Broadstreet HEOR, Vancouver, BC, Canada, ²Takeda Canada Inc., Toronto, ON, Canada, ³Unity Health, Toronto, ON, Canada.

Health-related Quality of Life (HRQoL) Impacts in Individuals With Hypophosphatasia (HPP): A Systematic Literature Review (SLR)

Eric T. Rush,¹ Suzanne McMullen,² Fernanda Nagase,² Antoinette Cheung,² Benit Maru,³ Kathryn M. Dahir^4
1Children’s Mercy Hospital, Kansas City, KS, USA, ²Broadstreet HEOR, Vancouver, BC, Canada, ³Alesta Therapeutics BV, Leiden, Netherlands, ⁴Vanderbilt University Medical Center, Nashville, TN, USA

Health-Related Quality-of-Life in Duchenne Muscular Dystrophy: Insights from the DMD-QoL Instrument in a US Population

Shelagh M Szabo,¹ Ania Filus,² Andrew Lloyd,³ Katherine L Gooch,² Melissa Bather,¹ Reem Mustafa,¹ Susan T Iannacone,⁴ Ivana F Audhya^2
1Broadstreet HEOR, Vancouver, BC; ²Sarepta Therapeutics, Inc., Cambridge, MA; ³Acaster Lloyd, London UK; ⁴The University of Texas Southwestern, Dallas TX USA.

Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS

Ivana Audhya,¹ Shelagh Szabo,² Ania Filus,¹ Evelyn Griffin,² Pramoda Jayasinghe,² David Feeny,³ Daniel Malone,⁴ Peter Neumann,⁵ Susan Iannaccone,⁶ Katherine L. Gooch^1
1Sarepta Therapeutics, Cambridge, MA, USA, ²Broadstreet HEOR, Vancouver, BC, Canada, ³McMaster University, Hamilton, ON, Canada, ⁴University of Utah, Salt Lake City, UT, USA, ⁵Tufts Medical Center, Boston, MA, USA, ⁶UT Southwestern, Dallas, TX, USA.

Understanding Treatment Preference Heterogeneity in Psoriasis: Insights from a Qualitative Analysis of Social Media Data

Shelagh Szabo, MSc, Neil Hawkins, MBA, MSc, PhD, Evi Germeni, PhD.
HEHTA, University of Glasgow, Glasgow, United Kingdom

If you have questions about any of these projects or how Broadstreet can support the development of your HEOR projects, please get in touch at info@broadstreetheor.com.